CVRx was founded in Minneapolis, MN in 2001 by Dr. Robert Kieval to develop an implantable system for the treatment of hypertension.
CVRx’s implantable pulse generators deliver stimulation to the baroeceptors in the carotid arteries to induce a baroreflex that causes a drop in blood pressure in patients with refractory hypertension.
On August 2011, CVRx received the CE Mark for its second-generation IPG for the treatment of uncontrolled hypertension – the Barostim neo™. The Barostim neo features a new unilateral, 1mm electrode, whch allows for a simpler implantation procedure than its predecesor, the Rheos IPG.
Company website: www.cvrx.com
Click here for CVRx’s patents.